Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Physiology
  • Track 1-2Diagnosis
  • Track 1-3Vascular systems
  • Track 1-4Circulatory diseases
  • Track 1-5Microcirculation
  • Track 1-6Specialization of vascular cells
  • Track 2-1Cardiovascular medicine
  • Track 2-2Peripheral artery disease
  • Track 2-3Coronary heart disease
  • Track 2-4Angioplasty and Stent
  • Track 2-5Aacute care vascular medicine
  • Track 2-6Thrombosis
  • Track 3-1Bypass surgery
  • Track 3-2Endoscopic perforator surgery
  • Track 3-3Aortobifemoral bypass
  • Track 3-4Acutecare vascular surgery
  • Track 3-5Resection
  • Track 3-6Endovascular grafting
  • Track 3-7Heart Failure and Transplantation Medicine
  • Track 4-1Nursing practice
  • Track 4-2Vascular surgical nursing
  • Track 4-3Cardiovascular nursing
  • Track 4-4Vascular healthcare
  • Track 4-5Nursing education
  • Track 5-1Cardiovascular imaging
  • Track 5-2Cardiovascular system
  • Track 5-3Cardiovascular medicine
  • Track 5-4Cardiovascular surgery
  • Track 5-5Cardiovascular diseases
  • Track 6-1Neovascularization
  • Track 6-2Vascular disrupting therapies
  • Track 6-3Tumor vasculature
  • Track 6-4Angiogenesis
  • Track 6-5Immunotherapy
  • Track 6-6Chemotherapy
  • Track 7-1Vascular embolism
  • Track 7-2Abdominal aortic aneurysm
  • Track 7-3Pulmonary embolism
  • Track 7-4Abdominal aortic aneurysms
  • Track 7-5Aortic dissection
  • Track 7-6Acute limb ischemia
  • Track 7-7Arteriovenous fistulae (AVFs)
  • Track 8-1Acute Management of Stroke
  • Track 8-2Basilar Artery Thrombosis
  • Track 8-3Cerebral Venous Thrombosis
  • Track 8-4Genetic and Inflammatory Mechanisms in Stroke
  • Track 8-5Hypertensive Encephalopathy
  • Track 8-6Lacunar Syndrome
  • Track 9-1Chronic venous insufficiency
  • Track 9-2Lymphatic diseases
  • Track 9-3Colorectal surgery
  • Track 9-4Thromboangitis
  • Track 9-5Vascular calcification
  • Track 9-6Thoracic aortic dissection
  • Track 10-1Aortic Stenosis
  • Track 10-2Neonatal lupus erythematosus
  • Track 10-3Childhood scleroderma
  • Track 10-4Arteriovenous malformations (AVM)
  • Track 10-5Coronary artery anomaly
  • Track 10-6Arterial and vascular respiratory therapy
  • Track 10-7Interventional cardiology
  • Track 11-1Scurvy
  • Track 11-2Marfan syndrome
  • Track 11-3Ehlers-Danlos Syndrome
  • Track 11-4Purpura simplex
  • Track 11-5Hereditary hemorrhagic telangiectasia
  • Track 11-6Dysproteinemias causing vascular purpura
  • Track 11-7Autoerythrocyte sensitization
  • Track 12-1Psychological therapy
  • Track 12-2Weight reduction
  • Track 12-3Non alcoholism and smoking
  • Track 12-4Exercise and yoga
  • Track 12-5Life style modifications
  • Track 12-6Food habits
  • Track 13-1Balloon angioplasty
  • Track 13-2Radiofrequency ablation (RF/RFA)
  • Track 13-3Electrophysiology study of the heart
  • Track 13-4Endovascular aneurysm repair
  • Track 13-5Embolization therapy
  • Track 13-6Thrombolysis
  • Track 14-1Ultrasound
  • Track 14-2Doppler ultrasound
  • Track 14-3Catheter angiography
  • Track 14-4Digital subtraction angiography
  • Track 14-5Intra vascular ultrasound
  • Track 14-6Magnetic resonance imaging
  • Track 14-7Power doppler
  • Track 15-1Stem cell therapy
  • Track 15-2Endothelial progenitor cell therapy
  • Track 15-3Trans-catheter aortic valve implantation
  • Track 15-4Minimally invasive bypass surgery
  • Track 15-5Trans-catheter aortic valve implantation
  • Track 15-6Gene therapy
  • Track 16-1Acute and chronic inflammation
  • Track 16-2Inflammatory diseases
  • Track 16-3Atherogenesis
  • Track 16-4Arterial hypertension
  • Track 16-5Anti-atherosclerotic therapies
  • Track 16-6Arteritis
  • Track 17-1Basic and Translational Research ipsc
  • Track 17-2Cell-free screening
  • Track 17-3Vascular targeting
  • Track 17-4Mitochondrial gene expression
  • Track 17-5Epigenetic, transcriptional and tumorigenic profiling
  • Track 17-6Genetic medicine
  • Track 18-1Vascular diabetology
  • Track 18-2Molecular studies
  • Track 18-3Tissue culture
  • Track 18-4Isolation
  • Track 18-5Metabolomics and genomics
  • Track 18-6Vascular biochemistry
  • Track 18-7Protein damage
  • Track 19-1Molecular biology
  • Track 19-2Basic and clinical translational methodologies
  • Track 19-3Hypothesis formulation
  • Track 19-4Cell therapy
  • Track 19-5Dose efficiency
  • Track 19-6Chronic remodeling
  • Track 19-7Experimental cardiology
  • Track 20-1Therapeutic drug monitoring in vascular pharmacotherapy
  • Track 20-2Individual patient drug regimen in vascular diseases
  • Track 20-3Basic pharmacotherapy in vascular diseases
  • Track 20-4Drug interactions in vascular pharmacotherapy
  • Track 20-5Advanced vascular pharmacotherapy
  • Track 20-6Adverse events in vascular pharmacotherapy